Fei Luo
Impact in
- Biochemistry top 5%
- Sulfur Compounds in Biology
-
- Diet, Metabolism, and Disease
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
- Surgery 15
- Lipoproteins and Cardiovascular Health 5
- Co-authors
- Xiangping Li (7 shared papers)Avash Das (5 shared papers)Zhenfei Fang (14 shared papers)Guiyun Ruan (5 shared papers)Ran Peng (3 shared papers)Yuan Guo (8 shared papers)Panyun Wu (8 shared papers)Jingfei Chen (11 shared papers)
- Journals
- Lipids in Health and Disease (12 papers)Journal of Cellular and Molecular Medicine (4 papers)World Journal of Microbiology and Biotechnology (3 papers)Frontiers in Cardiovascular Medicine (2 papers)Case Studies in Construction Materials (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Fei Luo
110 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 152
- Biochemistry 111
- Endocrinology, Diabetes and Metabolism 192
- Cancer Research 153
- Cardiology and Cardiovascular Medicine 163
- Epidemiology 230
Countries citing papers authored by Fei Luo
This map shows the geographic impact of Fei Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Luo more than expected).
Fields of papers citing papers by Fei Luo
This network shows the impact of papers produced by Fei Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Luo. The network helps show where Fei Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 185 | |
| 2 | 2019 | 126 | |
| 3 | 2021 | 92 | |
| 4 | 2016 | 80 | |
| 5 | 2020 | 69 | |
| 6 | 2021 | 64 | |
| 7 | 2023 | 59 | |
| 8 | 2017 | 54 | |
| 9 | 2014 | 44 | |
| 10 | 2023 | 38 | |
| 11 | 2023 | 35 | |
| 12 | 2017 | 33 | |
| 13 | 2022 | 33 | |
| 14 | 2017 | 32 | |
| 15 | 2023 | 27 | |
| 16 | 2024 | 26 | |
| 17 | 2023 | 25 | |
| 18 | 2019 | 24 | |
| 19 | 2025 | 23 | |
| 20 | 2017 | 23 |
About Fei Luo
Fei Luo is a scholar working on Molecular Biology, Surgery, Electrical and Electronic Engineering, Cancer Research and Cardiology and Cardiovascular Medicine, having authored 118 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lipid metabolism and disorders (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Cancer, Lipids, and Metabolism (6 papers), Lipoproteins and Cardiovascular Health (5 papers), Sulfur Compounds in Biology (5 papers), Advanced Battery Materials and Technologies (5 papers), Advancements in Battery Materials (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). The work is most often cited by research in Biochemistry (111 citations), Endocrinology, Diabetes and Metabolism (192 citations), Cancer Research (153 citations), Cardiology and Cardiovascular Medicine (163 citations) and Epidemiology (230 citations). Fei Luo has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Xiangping Li, Avash Das, Zhenfei Fang, Guiyun Ruan, Ran Peng, Yuan Guo, Panyun Wu, Jingfei Chen, Jia Peng and Federico Oldoni. Their work appears in journals such as Lipids in Health and Disease, Journal of Cellular and Molecular Medicine, World Journal of Microbiology and Biotechnology, Frontiers in Cardiovascular Medicine and Case Studies in Construction Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.